SCHEMBL8776090

SCHEMBL8776090

CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.79
HSD17B10 Q99714 2/20 0.61
TSHR P16473 1/20 0.61
MAPK1 P28482 1/20 0.61
CYP3A4 P08684 4/20 0.54
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.52
LMNA P02545 3/20 0.52
ESR1 P03372 3/20 0.52
PGR P06401 2/20 0.52
AR P10275 2/20 0.52
OPRM1 P35372 2/20 0.52
SLC6A3 Q01959 2/20 0.52
ADORA3 P0DMS8 1/20 0.52
CHRM1 P11229 1/20 0.52
TBXA2R P21731 1/20 0.52
ADRA1A P35348 1/20 0.52
ATM Q13315 1/20 0.52
MAPT P10636 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9747578 0.89 AKR1C3 (0.77) AKR1C3HSD17B10TSHRMAPK1CYP3A4
SCHEMBL9634078 0.89 LMNA (0.66) AKR1C3HSD17B10TSHRMAPK1CYP3A4
SCHEMBL10531128 0.89 LMNA (0.66) AKR1C3HSD17B10TSHRMAPK1CYP3A4
SCHEMBL15999637 0.88 AKR1C3 (1.00) AKR1C3HSD17B10TSHRMAPK1CYP3A4
SCHEMBL9111396 0.84 AKR1C3 (0.81) AKR1C3HSD17B10TSHRMAPK1CYP3A4
SCHEMBL8775995 0.83 AKR1C3 (0.58) AKR1C3HSD17B10TSHRMAPK1CYP3A4
SCHEMBL11692049 0.83 MEN1 (0.74) AKR1C3HSD17B10TSHRMAPK1CYP3A4
SCHEMBL15971654 0.83 MEN1 (0.74) AKR1C3HSD17B10TSHRMAPK1CYP3A4
SCHEMBL29198757 0.83 MEN1 (0.74) AKR1C3HSD17B10TSHRMAPK1CYP3A4
SCHEMBL11687810 0.83 MEN1 (0.74) AKR1C3HSD17B10TSHRMAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0719276-B1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE US HEALTH (US) 1997-11-26 EP disclosed
US-5554603-A 11,17-DINITRATES; USE TO ACHIEVE ESTROGENIC EFFECT IN FEMALE MAMMALS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-09-10 US disclosed
US-RE34136-E Morning-after contraceptives SRI INTERNATIONAL (US) 1992-12-01 US disclosed
EP-0227813-B1 11-BETA-NITRATE-SUBSTITUTED ESTRANES SRI INTERNATIONAL (US) 1991-10-02 EP disclosed
US-4859370-A 9 alpha, 11 beta-substituted and 11 beta-substituted estranes SRI INTERNATIONAL (US) 1989-08-22 US disclosed
US-4705783-A 9α, 11β-substituted and 11β-substituted estranes SRI INTERNATIONAL (US) 1987-11-10 US disclosed
WO-1987000175-A1 9alpha, 11beta-SUBSTITUTED AND 11beta-SUBSTITUTED ESTRANES SRI INTERNATIONAL (US) 1987-01-15 WO disclosed